Press release
Neuropathic Pain Therapeutics Market Outlook 2030: Projected to Reach US$ 10.2 Billion by 2030, Driven by Rising Prevalence and Therapeutic Advancements
Neuropathic Pain Therapeutics Market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77666
Market Overview
The Neuropathic Pain Therapeutics Market includes pharmaceuticals like gabapentin, pregabalin, duloxetine, and emerging non-opioid therapies for conditions such as diabetic neuropathy and postherpetic neuralgia. The market is expected to reach US$ 10.2 billion by 2030, driven by a CAGR of ~5%. It is segmented by drug class (anticonvulsants, antidepressants, opioids, others), indication (diabetic neuropathy, postherpetic neuralgia, chemotherapy-induced neuropathy, others), distribution channel (hospital pharmacies, retail pharmacies, online), end-user (hospitals, clinics, homecare), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Anticonvulsants dominate due to their efficacy, while hospitals lead as end-users.
Key Drivers of Growth
Several factors are propelling the growth of the Neuropathic Pain Therapeutics Market:
Rising Prevalence of Neuropathic Pain: Increasing cases, affecting 7-10% of the global population, drive demand for effective pain management therapies.
Growing Chronic Disease Incidence: Rising diabetes (over 500 million cases globally) and cancer rates increase neuropathic pain cases, boosting market growth.
Advancements in Therapeutics: Innovations in non-opioid drugs, topical treatments, and neuromodulation therapies enhance efficacy and reduce side effects.
Aging Population: The global elderly population, projected to reach 1.4 billion by 2030, increases neuropathic pain incidence, supporting market expansion.
Supportive Regulatory Approvals: Fast-track designations for novel pain therapies by agencies like the FDA and EMA facilitate market entry.
Top Companies:
Pfizer
Novartis AG
AstraZeneca
GlaxoSmithKline
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Abbott
Endo Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Merck & Co., Inc.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/neuropathic-pain-therapeutics-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
Side Effects of Therapies: Adverse effects like dizziness, dependency (opioids), or gastrointestinal issues reduce patient compliance.
Regulatory Complexities: Stringent regulations for controlled substances, particularly opioids, increase development costs and delay approvals.
Limited Access in Developing Regions: Inadequate healthcare infrastructure in Africa and parts of Asia-Pacific restricts market penetration.
High Treatment Costs: Advanced therapies and long-term treatment regimens are expensive, limiting affordability in low-income regions.
Competition from Alternatives: Non-pharmacological treatments like physical therapy and neuromodulation devices may reduce reliance on drugs.
Regional Insights
The Neuropathic Pain Therapeutics Market exhibits distinct regional dynamics:
North America: North America dominates, driven by high neuropathic pain prevalence, advanced healthcare systems, and robust R&D. The U.S. leads due to widespread drug availability.
Europe: Europe is a key market, with Germany, France, and the UK benefiting from strong healthcare policies and increasing diabetes rates.
Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising chronic disease prevalence, improving healthcare access, and investments in China, India, and Japan.
Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to expanding healthcare infrastructure. Limited awareness slows progress.
Middle East & Africa: This region has the smallest share due to limited healthcare access. Growth opportunities exist in Gulf countries with rising investments.
Future Opportunities
The Neuropathic Pain Therapeutics Market offers several avenues for growth and innovation:
Non-Opioid Therapies: Developing novel non-opioid drugs and biologics could address safety concerns and drive market demand.
Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable treatment solutions.
Personalized Medicine: Tailoring therapies to patient-specific pain profiles could improve efficacy and market growth.
Digital Health Integration: Telemedicine and AI-driven pain management tools could enhance patient monitoring and adherence.
Partnerships with Pharma Companies: Collaborations can accelerate development and distribution of innovative neuropathic pain therapies.
Browse More Trending Research Reports:
Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html
Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Therapeutics Market Outlook 2030: Projected to Reach US$ 10.2 Billion by 2030, Driven by Rising Prevalence and Therapeutic Advancements here
News-ID: 4091130 • Views: …
More Releases from Transparency Market Research
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035.
Gain a preview of important insights from…
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035.
Access key findings…
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)…
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035.
Access key…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
